Cover Image

Individualized Absorption Models in Population Pharmacokinetic Analyses

Saved in:

Bibliographic Details
Main Authors:	Mutaz M. Jaber (Author), Mahmoud Al‐Kofahi (Author), Kyriakie Sarafoglou (Author), Richard C. Brundage (Author)
Format:	Book
Published:	Wiley, 2020-06-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Application of Deep Neural Networks as a Prescreening Tool to Assign Individualized Absorption Models in Pharmacokinetic Analysis
by: Mutaz M. Jaber, et al.
Published: (2021)

Evaluation of bias in weighted residual calculations when handling below the limit of quantification data using Beal's M3 method
by: Mutaz M. Jaber, et al.
Published: (2021)

Bridging population pharmacokinetic and semimechanistic absorption modeling of APX3330
by: Larissa L. Silva, et al.
Published: (2024)

Pharmacokinetic-Pharmacodynamic Modeling of Tumor Targeted Drug Delivery Using Nano-Engineered Mesenchymal Stem Cells
by: Shen Cheng, et al.
Published: (2021)

No Time Dependence of Ciprofloxacin Pharmacokinetics in Critically Ill Adults: Comparison of Individual and Population Analyses
by: Martin Šíma, et al.
Published: (2021)

Pharmacokinetics and absorption mechanism of tandospirone citrate
by: Rong Li, et al.
Published: (2023)

The influence of flip‐flop in population pharmacokinetic analyses
by: Isabelle H. S. Kuan, et al.
Published: (2023)

Physiologically Based Pharmacokinetic Modeling to Understand the Absorption of Risperidone Orodispersible Film
by: Fang Chen, et al.
Published: (2020)

Population pharmacokinetics and exposure‐response modeling analyses of guselkumab in patients with psoriatic arthritis
by: Yang Chen, et al.
Published: (2022)

Population pharmacokinetics modeling and exposure‐response analyses of cemiplimab in patients with recurrent or metastatic cervical cancer
by: Jenny‐Hoa Nguyen, et al.
Published: (2022)

Predicting Oral Drug Absorption: Mini Review on Physiologically-Based Pharmacokinetic Models
by: Louis Lin, et al.
Published: (2017)

Population pharmacokinetic analyses for belzutifan to inform dosing considerations and labeling
by: Dhananjay D. Marathe, et al.
Published: (2023)

Drug Nanocrystals in Oral Absorption: Factors That Influence Pharmacokinetics
by: Luiza de Oliveira Macedo, et al.
Published: (2024)

Lymphatic Drug Absorption via the Enterocytes: Pharmacokinetic Simulation, Modeling, and Considerations for Optimal Drug Development
by: Dion R. Brocks, et al.
Published: (2018)

Population pharmacokinetics and exposure-response analyses of varenicline in adolescent smokers
by: Daryl J. Fediuk, et al.
Published: (2021)

A Bayesian Approach for Population Pharmacokinetic Modeling of Alcohol in Japanese Individuals
by: Asuka Nemoto, MPharm, ME, et al.
Published: (2017)

Meta-Assessment of Metformin Absorption and Disposition Pharmacokinetics in Nine Species
by: Yoo-Seong Jeong, et al.
Published: (2021)

Population pharmacokinetic and exposure‐response analyses from ALTA‐1L: Model‐based analyses supporting the brigatinib dose in ALK‐positive NSCLC
by: Neeraj Gupta, et al.
Published: (2022)

The pharmacokinetics of valganciclovir prophylaxis in pediatric solid organ transplant patients at risk for Epstein–Barr virus disease
by: Heather E Vezina, et al.
Published: (2009)

Pharmacokinetic and pharmacodynamic evaluation according to absorption differences in three formulations of ibuprofen
by: Shin D, et al.
Published: (2017)

Pharmacokinetics, absorption, distribution, metabolism and excretion of the MEK inhibitor zapnometinib in rats
by: Yvonne Füll, et al.
Published: (2022)

Food Effects on Oral Drug Absorption: Application of Physiologically-Based Pharmacokinetic Modeling as a Predictive Tool
by: Lisa Cheng, et al.
Published: (2020)

Pharmacokinetic Models to Characterize the Absorption Phase and the Influence of a Proton Pump Inhibitor on the Overall Exposure of Dacomitinib
by: Ana Ruiz-Garcia, et al.
Published: (2020)

A mechanism-based pharmacokinetic model of fenofibrate for explaining increased drug absorption after food consumption
by: Hyun-moon Back, et al.
Published: (2018)

Pharmacokinetics and Pharmacodynamics: A Comprehensive Analysis of the Absorption, Distribution, Metabolism, and Excretion of Psychiatric Drugs
by: Zainab Zakaraya, et al.
Published: (2024)

Ustekinumab Dosing Individualization in Crohn's Disease Guided by a Population Pharmacokinetic-Pharmacodynamic Model
by: Jurij Aguiar Zdovc, et al.
Published: (2021)

Tacrolimus pharmacokinetics in pediatric nephrotic syndrome: A combination of population pharmacokinetic modelling and machine learning approaches to improve individual prediction
by: Qiongbo Huang, et al.
Published: (2022)

Optimization of the Factors Affecting the Absorption of Vardenafil from Oral Disintegrating Tablets: A Clinical Pharmacokinetic Investigation
by: Hytham A. Al-Gethmy, et al.
Published: (2019)

Population pharmacokinetics and exposure‐response analyses for efficacy and safety of upadacitinib in patients with axial spondyloarthritis
by: Sumit Bhatnagar, et al.
Published: (2024)

Implementing Vancomycin Population Pharmacokinetic Models: An App for Individualized Antibiotic Therapy in Critically Ill Patients
by: Manuel Mena, et al.
Published: (2023)

rhIGF-1 Therapy for Growth Failure and IGF-1 Deficiency in Congenital Disorder of Glycosylation Ia ( Deficiency)
by: Bradley S. Miller MD, PhD, et al.
Published: (2013)

Clofazimine pharmacokinetics in HIV‐infected adults with diarrhea: Implications of diarrheal disease on absorption of orally administered therapeutics
by: Cindy X. Zhang, et al.
Published: (2024)

Population pharmacokinetic and exposure‐response analyses of pemigatinib in patients with advanced solid tumors including cholangiocarcinoma
by: Xiaohua Gong, et al.
Published: (2023)

Population pharmacokinetic and exposure-response analyses of intravenous and subcutaneous rituximab in patients with chronic lymphocytic leukemia
by: Ekaterina Gibiansky, et al.
Published: (2021)

Population pharmacokinetics and exposure‐response analyses of teduglutide in adult and pediatric patients with short bowel syndrome
by: Jean‐Francois Marier, et al.
Published: (2021)

Establishment of a population pharmacokinetics model of vancomycin in 94 infants with septicemia and its application in individualized therapy
by: Zhiling Li, et al.
Published: (2021)

Population pharmacokinetics of liposomal irinotecan in patients with cancer and exposure-safety analyses in patients with metastatic pancreatic cancer
by: Karl Brendel, et al.
Published: (2021)

Modeling Pharmacokinetics in Individual Patients Using Therapeutic Drug Monitoring and Artificial Population Quasi-Models: A Study with Piperacillin
by: Gellért Balázs Karvaly, et al.
Published: (2024)

A novel method to estimate the absorption rate constant for two-compartment model fitted drugs without intravenous pharmacokinetic data
by: Fan Liu, et al.
Published: (2023)

Mosaicism of the UDP-Galactose transporter SLC35A2 in a female causing a congenital disorder of glycosylation: a case report
by: Kristen Westenfield, et al.
Published: (2018)